Improved glycaemic control and treatment satisfaction with a simple wearable 3‐day insulin delivery device among people with Type 2 diabetes

AIM: To evaluate the PAQ (®) (CeQur SA, Horw, Switzerland), a wearable 3‐day insulin delivery device that provides set basal rates and bolus insulin on demand, in people with Type 2 diabetes. METHOD: Adults with Type 2 diabetes with HbA(1c) concentrations ≥53 and ≤97 mmol/mol (7.0 and 11.0%) while t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Diabet Med
Egile Nagusiak: Mader, J. K., Lilly, L. C., Aberer, F., Poettler, T., Johns, D., Trautmann, M., Warner, J. L., Pieber, T. R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2018
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6175230/
https://ncbi.nlm.nih.gov/pubmed/29888811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dme.13708
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak